Skip to main content

Table 4 Frequent findings in TSC patients based on mTORi prescription

From: Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex

 

Kidney cysts

Kidney fat-containing AML

Kidney lipid-poor AML

Liver AML

Lung cysts

Lung nodules

mTORi prescribed (N = 186)

146 (79%)

110 (59%)

60 (32%)

41 (22%)

21 (11%)

40 (22%)

mTORi not prescribed (N = 463)

320 (69%)

224 (48%)

117 (25%)

83 (18%)

56 (12%)

79 (17%)

  1. AML angiomyolipoma, mTORi mTOR inhibitor